Elizabeth G. O’Farrell
Lead Chairperson, Audit Committee (Chair)
Elizabeth G. O’Farrell has served as a director of Geron since March 2019.
Ms. O’Farrell also serves as a member of the board of directors of Inhibikase Therapeutics since December 2020 and LENSAR, Inc. since January 2021. In December 2017, Ms. O’Farrell retired from a 24-year career with Eli Lilly and Company where she held several senior management positions in finance and corporate governance, most recently serving as Chief Procurement Officer and Head of Global Shared Services from January 2012 to December 2017.
Prior to that position, she also served as Senior Vice President, Policy and Finance; Senior Vice President, Finance; Chief Financial Officer, Lilly USA; Chief Financial Officer, Lilly Canada; and General Auditor. Before joining Eli Lilly, Ms. O’Farrell was an accountant with Boise Cascade Office Products, and served as an auditor at Whipple & Company and Price Waterhouse. Ms. O’Farrell holds a B.S. in accounting with honors and an M.B.A. in management information systems, both from Indiana University.